Literature DB >> 9775407

Parotid cancer.

N D Stafford1, A Wilde.   

Abstract

Parotid cancers are relatively rare but will be encountered in any head and neck oncology practice. Their histopathological diversity merits a specific classification, particularly as prognosis is often closely associated with histological type. Tumour stage is also of prognostic significance. Diagnostic value of aspiration cytology and frozen section analysis remains unresolved for this group of tumours. Surgery remains the mainstay of treatment with primary rather than delayed reconstruction of the facial nerve should this be required.

Entities:  

Mesh:

Year:  1997        PMID: 9775407     DOI: 10.1016/s0960-7404(98)00008-5

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  7 in total

1.  [2014: activation of OPS 8-980 "Complex intensive care treatment" by DIMDI].

Authors:  L Engelmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-12-20       Impact factor: 0.840

2.  Tumours of Deep Lobe of Parotid Gland: Our Experience.

Authors:  Arjun Dass; Nitin Gupta; S K Singhal; Hitesh Verma
Journal:  Indian J Surg       Date:  2014-04-15       Impact factor: 0.656

3.  Postoperative [¹²⁵I] seed brachytherapy in the treatment of acinic cell carcinoma of the parotid gland: with associated risk factors.

Authors:  Ming-Hui Mao; Jian-Guo Zhang; Jie Zhang; Lei Zheng; Shu-Ming Liu; Ming-Wei Huang; Yan Shi
Journal:  Strahlenther Onkol       Date:  2014-04-29       Impact factor: 3.621

4.  Parotid cancer treatment with surgery followed by radiotherapy in Oxford over 15 years.

Authors:  Ketan Shah; Faisal Javed; Chris Alcock; Ketan A Shah; Pieter Pretorius; Chris A Milford
Journal:  Ann R Coll Surg Engl       Date:  2011-04       Impact factor: 1.891

5.  125I seed implant brachytherapy for the treatment of parotid gland cancers in children and adolescents.

Authors:  L Zheng; J Zhang; T Song; J Zhang; G Yu; Y Zhang
Journal:  Strahlenther Onkol       Date:  2013-03-23       Impact factor: 3.621

Review 6.  Synchronous bilateral epithelial-myoepithelial carcinoma of the parotid gland: case report and review of the literature.

Authors:  J van Tongeren; D H K V Creytens; E V Meulemans; R B J de Bondt; J de Jong; J J Manni
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-10-08       Impact factor: 2.503

7.  S100A4 overexpression proves to be independent marker for breast cancer progression.

Authors:  Nawfal I Ismail; Gurjeet Kaur; Hasnah Hashim; Mohammed S Hassan
Journal:  Cancer Cell Int       Date:  2008-09-05       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.